- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07937917
Transcutaneous Spinal Cord Stimulation for Motor Recovery After Spinal Cord Injury
Restoring Upper and Lower Extremity Functions in Persons With Spinal Cord Injury by Transcutaneous Spinal Cord Stimulation
This study will examine the safety, feasibility, and potential benefits of transcutaneous spinal cord stimulation (scTS) combined with activity-based training in people with spinal cord injury.
The study will include 10 adults with chronic, incomplete spinal cord injury. Electrical stimulation will be delivered through electrodes placed on the skin over different regions of the spinal cord, while participants perform exercises involving the arms, hands, trunk, and legs.
Participants will undergo initial assessments, individualized stimulation mapping, and 80 training sessions, followed by final assessments. Researchers will evaluate changes in motor function, muscle activity, psychological well-being, autonomic function, and quality of life. Safety and tolerability will also be monitored throughout the study.
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
This prospective, single-arm, within-subject exploratory study will enroll 10 adults aged 18-65 years with chronic incomplete cervical or thoracic spinal cord injury.
The study includes four phases: (1) baseline assessments over approximately two months; (2) stimulation mapping and optimization over approximately 0.5-1 month to identify individualized stimulation parameters; (3) 80 sessions of multisegment transcutaneous spinal cord stimulation combined with activity-based training, delivered 3-5 days per week over approximately 4-7 months; and (4) follow-up assessments.
The intervention targets upper and lower extremity function, trunk control, standing, and stepping. Motor performance will be assessed primarily using the Neuromuscular Recovery Scale (NRS). Additional assessments will examine muscle activation using electromyography (EMG), psychological symptoms, autonomic function, neurological status, spasticity, functional independence, and quality of life.
Intermediate assessments will be conducted during the intervention, including after 40 training sessions. Safety, adverse events, and feasibility will be evaluated throughout the study.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Amihai Gottlieb, Ph.D
- Número de teléfono: +972543323180
- Correo electrónico: amihai.gottlieb@gmail.com
Ubicaciones de estudio
-
-
-
Ramat Gan, Israel
- Sheba Medical Center
-
Contacto:
- Amihai Gottlieb
- Número de teléfono: +972543323180
- Correo electrónico: amihai.gottlieb@gmail.com
-
Sub-Investigador:
- Einat Haber, M.D.
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- At least 18 years of age.
- Non-progressive cervical or thoracic (>T10) spinal cord injury (SCI), with the ability to voluntarily move at least three joints below the injury level.
- At least 6 months post spinal cord injury.
- Stable medical condition.
- Neuromuscular Recovery Scale (NRS) score <4C on any upper extremity, trunk, or standing/stepping item.
Exclusion Criteria:
- Ventilator dependence.
- Untreated or unstable fracture or pressure ulcer.
- Untreated psychiatric disorder or ongoing drug abuse.
- Cardiac, respiratory, bladder, renal, or other medical disorder that may interfere with the study.
- Skeletal muscle Botox injections within the previous 6 months.
- Previous nerve or tendon transfer of the arms or legs.
- Any implanted pump (e.g., baclofen pump or pain pump).
- Unable or unwilling to discontinue anti-spasticity medications.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Multisegment scTS + Activity-Based Training
Participants will receive individualized multisegment transcutaneous spinal cord stimulation (scTS) combined with activity-based training targeting upper and lower extremity function, trunk control, standing, and stepping. The intervention will consist of 80 training sessions, delivered 3-5 days per week over approximately 4-7 months, with sessions lasting up to 2 hours. |
Non-invasive electrical stimulation delivered through surface electrodes placed over multiple spinal levels using the NeoStim-5 system. Stimulation sites and parameters will be individually optimized to facilitate motor activation of the upper extremities, trunk, and lower extremities during activity-based training. Individualized, task-specific rehabilitation training targeting voluntary control of the hands, arms, trunk, and legs, including seated activities, standing, and stepping. Training will be provided by rehabilitation staff and combined with transcutaneous spinal cord stimulation. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Motor Function (NRS)
Periodo de tiempo: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in motor performance assessed using the Neuromuscular Recovery Scale (NRS), which evaluates movement quality and the level of assistance required during upper extremity, trunk, standing, and stepping tasks. Changes in individual task ratings will be assessed across study time points. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
Safety
Periodo de tiempo: From enrollment through the final study assessment (approximately 7-10 months per participant).
|
Incidence of adverse events and equipment-related complications during the study. Adverse events will be categorized by severity, relatedness to study procedures, and expectedness. |
From enrollment through the final study assessment (approximately 7-10 months per participant).
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Surface EMG Amplitude During Functional Motor Tasks
Periodo de tiempo: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in surface electromyography (EMG) signal amplitude during functional motor tasks involving upper extremity, trunk, and lower extremity muscles. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
Depression (PHQ-9)
Periodo de tiempo: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in depressive symptoms measured using the 9-item Patient Health Questionnaire (PHQ-9). Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
Anxiety (GAD-7)
Periodo de tiempo: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in anxiety symptoms measured using the 7-item Generalized Anxiety Disorder scale (GAD-7). Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
PTSD (PCL-5)
Periodo de tiempo: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training)
|
Changes in self-reported post-traumatic stress symptoms measured using the PTSD Checklist for DSM-5 (PCL-5). Total scores range from 0 to 80, with higher scores indicating greater symptom severity. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training)
|
|
PTSD (CAPS-5)
Periodo de tiempo: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in clinician-rated post-traumatic stress symptom severity measured using the CAPS-5. The total severity score ranges from 0 to 80, with higher scores indicating greater symptom severity. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
Change in ISNCSCI Total Motor Score
Periodo de tiempo: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in motor function assessed using the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI). The total motor score ranges from 0 to 100, with higher scores indicating better motor function. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Modified Ashworth Scale (MAS) Score
Periodo de tiempo: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in muscle spasticity assessed by a clinician using the Modified Ashworth Scale, which grades resistance to passive movement. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET) Score
Periodo de tiempo: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in the self-reported impact of spasticity on daily activities, assessed using the SCI-SET questionnaire covering the preceding seven days. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) Questionnaire Score
Periodo de tiempo: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in frequency and severity of symptoms associated with blood pressure instability, assessed using the 24-item ADFSCI questionnaire. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Modified Functional Reach Test Distance
Periodo de tiempo: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in maximum forward reaching distance while seated, measured using the Modified Functional Reach Test |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Activity-Based Balance Level (ABLE) Sitting Subscale Score
Periodo de tiempo: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in sitting balance assessed using the seven items of the ABLE sitting subscale, with a maximum score of 32. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- SHEBA-26-3283-GZ-CTIL
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .